Weight Loss
12
 min read

Does Fatty Liver Affect Fertility?

Written by
Bolt Pharmacy
Published
30/9/2026
Last Updated

Fatty liver disease and fertility are more closely connected than many people realise. Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease, can disrupt the hormonal environment needed for conception in both women and men. Through mechanisms including insulin resistance, impaired sex hormone metabolism and chronic low-grade inflammation, fatty liver may reduce the chances of getting pregnant. This article explains how fatty liver affects reproductive health, what lifestyle changes can help, and when to seek medical advice.

Summary: Fatty liver disease can reduce fertility in both women and men by disrupting sex hormone metabolism, promoting insulin resistance and impairing the hormonal signalling needed for conception.

  • MASLD (formerly NAFLD) is closely linked to insulin resistance and obesity, both of which independently reduce fertility in women and men.
  • The liver metabolises sex hormones including oestrogen and testosterone; fat accumulation and inflammation can impair this process, causing hormonal imbalances.
  • In women, fatty liver is associated with ovulatory dysfunction and frequently co-exists with PCOS, a leading cause of female infertility.
  • In men, fatty liver is associated with lower testosterone, reduced SHBG and poorer sperm quality, largely through observational evidence.
  • Modest weight loss of around 5 per cent of body weight can reduce hepatic steatosis and improve insulin sensitivity, supporting both liver and reproductive health.
  • NICE guidance recommends GP assessment after 12 months of unsuccessful conception (6 months if over 35), with earlier review if fatty liver, PCOS or insulin resistance is present.

Can fatty liver disease affect your chances of getting pregnant?

Fatty liver disease is associated with reduced fertility in both sexes by disrupting hormonal balance, impairing ovulation in women and reducing sperm quality in men, largely through insulin resistance and impaired liver metabolism of sex hormones.

Fatty liver disease is associated with reduced fertility in both women and men, with evidence suggesting that metabolic liver disease disrupts the hormonal and physiological conditions needed for conception. Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is closely linked to insulin resistance, obesity and type 2 diabetes, all of which are independently associated with reduced fertility.[1][3] In women, these metabolic disturbances may impair ovulation and reduce egg quality. MASLD and polycystic ovary syndrome (PCOS) frequently co-exist through shared metabolic risk factors, including insulin resistance and obesity, and PCOS is itself a leading cause of female infertility.[5][6] In men, fatty liver disease has been associated with lower testosterone levels, reduced sperm quality and impaired sperm motility, though much of this evidence is observational.[7][8]

The relationship between fatty liver and fertility is not simply coincidental. The liver plays a central role in metabolising sex hormones, including oestrogen and testosterone. When liver function is compromised by fat accumulation and inflammation, this metabolic processing may become less efficient, potentially contributing to hormonal imbalances that can interfere with reproductive function.

Fatty liver disease is increasingly common in the UK. The NHS and British Liver Trust note that MASLD affects a substantial proportion of the adult population, with estimates varying by diagnostic method and population studied. Recognising the link between liver health and fertility is an important first step. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, which may be relevant for those whose fertility concerns are connected to metabolic health.

Factor Effect on Fertility in Women Effect on Fertility in Men Key Mechanism
Insulin resistance Ovarian androgen excess, suppressed SHBG, impaired ovulation Reduced SHBG, lower total testosterone Hyperinsulinaemia drives androgen excess and disrupts hormonal balance
Hormonal processing impairment Relative oestrogen excess may disrupt menstrual cycle and luteal phase Reduced testosterone-to-oestrogen ratio via aromatisation in adipose tissue Hepatic fat accumulation reduces efficiency of sex hormone metabolism
PCOS co-existence Leading cause of female infertility; shares metabolic risk factors with MASLD Not applicable Shared pathways of insulin resistance and obesity link MASLD and PCOS
Chronic low-grade inflammation May disrupt hypothalamic-pituitary-gonadal axis signalling May disrupt hypothalamic-pituitary-gonadal axis signalling Pro-inflammatory cytokines (TNF-alpha, IL-6) interfere with reproductive hormonal axis
Sperm quality Not applicable Reduced sperm count, motility and libido observed in observational studies Lower testosterone and elevated oestradiol associated with impaired spermatogenesis
Weight loss (5 to 10 per cent body weight) Reduces hepatic steatosis, improves insulin sensitivity, supports ovulation Reduces visceral fat, may improve testosterone levels and sperm parameters NICE NG49 recommends weight loss as key management strategy for MASLD
Lifestyle interventions Mediterranean diet, 150 min aerobic activity per week, alcohol avoidance support hormonal balance Smoking cessation and exercise improve sperm parameters and reduce visceral fat Reduced insulin resistance and liver inflammation benefit reproductive function in both sexes

How does fatty liver disrupt hormones linked to fertility?

Fatty liver impairs the liver's ability to clear sex hormones and lowers SHBG, increasing free androgens in women and reducing testosterone in men, both of which can disrupt ovulation and sperm production.

Fatty liver disease may disrupt fertility-related hormones primarily by impairing the liver's ability to metabolise and clear sex hormones. When hepatic fat accumulation triggers inflammation and reduces liver cell efficiency, hormonal processing may be compromised, potentially creating an environment of hormonal imbalance that undermines reproductive health. The magnitude of these effects varies between individuals and is often confounded by the degree of adiposity.

In women, relative excess of oestrogen compared with progesterone may disrupt the menstrual cycle, impair the luteal phase and reduce the likelihood of successful implantation. Insulin resistance, which frequently accompanies fatty liver disease, is associated with ovarian androgen excess, contributing to the hormonal profile seen in PCOS. The established mechanisms in PCOS involve hyperandrogenism and insulin resistance rather than oestrogen excess alone. Elevated insulin is also associated with suppression of sex hormone-binding globulin (SHBG), a protein that regulates the availability of active sex hormones in the bloodstream. Lower SHBG means more free androgens may circulate, potentially disrupting ovulation.

In men, fatty liver disease is associated with reduced SHBG and lower total testosterone, which may impair sperm production and libido. Adipose tissue, which is often increased in people with fatty liver, can convert testosterone to oestradiol via a process called aromatisation, potentially lowering the testosterone-to-oestrogen ratio. This hormonal shift has been associated with reduced sperm count and motility, though the evidence is largely observational.

Chronic low-grade inflammation associated with MASLD raises levels of pro-inflammatory cytokines such as tumour necrosis factor-alpha and interleukin-6. These inflammatory mediators may interfere with the hypothalamic-pituitary-gonadal axis, the hormonal signalling pathway that governs reproductive function in both sexes, though direct causal evidence in humans remains limited and this area continues to be studied.

What lifestyle changes can improve both liver health and fertility?

A Mediterranean-style diet, modest weight loss of 5 to 10 per cent of body weight, at least 150 minutes of weekly aerobic activity and alcohol avoidance can improve hepatic steatosis, insulin sensitivity and hormonal balance.

Adopting a balanced, nutrient-dense diet and achieving a modest reduction in body weight are among the most effective lifestyle changes for improving both liver health and fertility simultaneously. NICE guidance on NAFLD (NG49) recommends weight loss as a key management strategy, with greater degrees of weight loss (in the region of 7 to 10 per cent of body weight) associated with greater histological and metabolic benefit. Modest weight loss of around 5 per cent has been shown to reduce hepatic steatosis and improve insulin sensitivity, though more substantial loss is generally needed to reduce liver inflammation and fibrosis.[1] Both improvements support hormonal balance and may benefit reproductive function.

Dietary changes that benefit the liver also tend to support fertility. A Mediterranean-style diet, rich in vegetables, wholegrains, legumes, oily fish and olive oil, has evidence supporting its role in reducing hepatic steatosis and may support fertility outcomes, though direct evidence on ovarian function specifically is limited. Reducing intake of ultra-processed foods, refined carbohydrates and added sugars is particularly important, as these drive insulin resistance, a key mechanism linking fatty liver to impaired fertility. Alcohol should be minimised or avoided entirely, as it directly contributes to liver fat accumulation and can disrupt sex hormone metabolism. For those who are trying to conceive, avoiding alcohol altogether is the safest approach, in line with NHS guidance.

Regular physical activity is independently beneficial for both liver health and fertility. UK Chief Medical Officers and NHS guidance recommends at least 150 minutes of moderate-intensity aerobic activity per week for adults, and evidence suggests that resistance training alongside aerobic exercise is particularly effective at reducing visceral fat and improving insulin sensitivity.[10][11] Smoking cessation is also advisable, as smoking is associated with reduced ovarian reserve in women and poorer sperm parameters in men.[12]

For those whose weight is a significant contributing factor, a structured weight-management programme may be appropriate. NHS weight-management services can provide support, and your GP can advise on referral. Addressing sleep quality and managing psychological stress are also worthwhile, as both poor sleep and chronic stress can elevate cortisol, which may further disrupt the hormonal axis governing reproduction.

When should you see a doctor about fatty liver and fertility concerns?

See your GP after 12 months of unsuccessful conception (or 6 months if over 35), sooner if you have a known diagnosis of fatty liver, PCOS or insulin resistance, as these warrant earlier fertility investigation and liver assessment.

You should see your GP if you have been trying to conceive for 12 months without success (or 6 months if you are over 35), particularly if you have a known diagnosis of fatty liver disease, obesity, insulin resistance or PCOS, as these conditions warrant earlier investigation. NICE guidance (CG156) recommends that GPs offer initial fertility investigations to both partners at this stage. A diagnosis of MASLD should be disclosed as part of that assessment, as it may influence the investigations requested and the management plan offered.

If you have been diagnosed with fatty liver disease and are planning a pregnancy, it is sensible to discuss this with your GP before trying to conceive. For women, NICE CG156 recommends mid-luteal serum progesterone as the first-line test to confirm ovulation.[2] Tests such as AMH, FSH, LH and oestradiol are not routinely recommended in primary care for predicting natural fertility, though your GP may consider TSH and prolactin if there are clinical reasons to do so.[2] For men, a semen analysis is a standard first-line investigation. Your GP may also arrange liver function tests, a fasting glucose or HbA1c, and a lipid profile to assess the extent of metabolic liver disease. In line with NICE NG49, your GP may use a FIB-4 score (a calculation based on age, liver enzyme levels and platelet count) to assess the risk of liver fibrosis and determine whether referral to a hepatologist is appropriate.[1]

You should seek prompt medical advice, rather than waiting for a routine appointment, if you experience symptoms that may indicate worsening liver disease, such as persistent right upper abdominal discomfort, unexplained fatigue, or jaundice (yellowing of the skin or whites of the eyes). You should contact NHS 111 or seek urgent medical attention if you develop symptoms that may suggest decompensated liver disease, including significant abdominal swelling, confusion or disorientation, vomiting blood, or passing very dark or tarry stools, as these require prompt assessment.

Referral to a hepatologist, endocrinologist or reproductive medicine specialist may be appropriate depending on the findings. Your GP is best placed to coordinate this, and early engagement with the right specialist team can meaningfully improve outcomes for both liver health and fertility.

Scientific References

  1. .
  2. .
  3. .
  4. .
  5. .
  6. .
  7. .
  8. .
  9. .
  10. .
  11. .
  12. .

Frequently Asked Questions

Can treating fatty liver disease improve fertility?

Improving liver health through weight loss, dietary changes and increased physical activity can reduce insulin resistance and restore hormonal balance, which may improve fertility outcomes in both women and men. However, anyone with ongoing fertility concerns should seek assessment from their GP.

Does fatty liver disease affect male fertility as well as female fertility?

Yes. In men, fatty liver disease is associated with lower testosterone levels, reduced sex hormone-binding globulin and poorer sperm quality and motility, all of which can reduce male fertility. A semen analysis is the standard first-line investigation recommended by GPs.

Is PCOS linked to fatty liver disease?

PCOS and MASLD frequently co-exist because they share common metabolic risk factors, particularly insulin resistance and obesity. PCOS is a leading cause of female infertility, and women with PCOS should be assessed for fatty liver disease as part of their overall metabolic health review.


Disclaimer & Editorial Standards

The health-related content published on this site is based on credible scientific sources and is periodically reviewed to ensure accuracy and relevance. Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only.

The information on this site is not a substitute for professional medical advice. For any health concerns, please speak with a qualified medical professional. By using this information, you acknowledge responsibility for any decisions made and understand we are not liable for any consequences that may result.

Any third-party brands or services referenced on this site are included for informational purposes only; we are entirely independent and have no affiliation, partnership, or collaboration with any companies mentioned.